Amy Feng, PhD

Amy Feng is the Vice President of Biometrics and Data Management at Braveheart Bio. She is a distinguished biostatistician with nearly two decades of leadership in global clinical trials. She has successfully led biometrics functions across all phases of drug development, driving strategic decision-making, regulatory submissions, and cross-functional collaborations that accelerate innovative therapies to patients worldwide.

Amy previously held senior leadership roles at a number of biotechnology companies, where she built and scaled biometrics organizations, guided clinical development strategies, and partnered closely with clinical, regulatory, and medical teams to deliver high-impact programs. She is recognized for her expertise in innovative trial design, data strategy, and regulatory engagement. Amy earned her PhD in Statistical Science from Baylor University.

‍

‍